Patents by Inventor Sandrine CRABE

Sandrine CRABE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations including ABX196 for the treatment of cancer
    Patent number: 11826372
    Abstract: An antitumor pharmaceutical combination includes (i) a compound ABX196 and (ii) at least one chemotherapeutic agent and/or at least one immunotherapeutic agent, for use in the treatment of cancer.
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: November 28, 2023
    Assignee: ABIVAX
    Inventors: Sandrine Crabe, Didier Scherrer, Hartmut Ehrlich, Philippe Pouletty
  • COMBINATIONS INCLUDING ABX196 FOR THE TREATMENT OF CANCER
    Publication number: 20220193089
    Abstract: An antitumor pharmaceutical combination includes (i) a compound ABX196 and (ii) at least one chemotherapeutic agent and/or at least one immunotherapeutic agent, for use in the treatment of cancer.
    Type: Application
    Filed: December 6, 2021
    Publication date: June 23, 2022
    Applicant: ABIVAX
    Inventors: Sandrine CRABE, Didier SCHERRER, Hartmut EHRLICH, Philippe POULETTY
  • Combinations including ABX196 for the treatment of cancer
    Patent number: 11278552
    Abstract: An antitumor pharmaceutical combination includes (i) a compound ABX196 and (ii) at least one chemotherapeutic agent and/or at least one immunotherapeutic agent, for use in the treatment of cancer.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: March 22, 2022
    Assignee: Abivax
    Inventors: Sandrine Crabe, Didier Scherrer, Hartmut Ehrlich, Philippe Pouletty
  • ABX196 for use in the treatment of bladder cancer
    Patent number: 11266667
    Abstract: The compound ABX196 and pharmaceutical compositions including ABX196 are used in the treatment of bladder cancer.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: March 8, 2022
    Assignee: ABIVAX
    Inventors: Sandrine Crabe, Didier Scherrer, Hartmut Ehrlich, Philippe Pouletty
  • ABX196 FOR USE IN THE TREATMENT OF BLADDER CANCER
    Publication number: 20200230163
    Abstract: The compound ABX196 and pharmaceutical compositions including ABX196 are used in the treatment of bladder cancer.
    Type: Application
    Filed: September 13, 2018
    Publication date: July 23, 2020
    Inventors: Sandrine CRABE, Didier SCHERRER, Hartmut EHRLICH, Philippe POULETTY
  • COMBINATIONS INCLUDING ABX196 FOR THE TREATMENT OF CANCER
    Publication number: 20190328747
    Abstract: An antitumor pharmaceutical combination includes (i) a compound ABX196 and (ii) at least one chemotherapeutic agent and/or at least one immunotherapeutic agent, for use in the treatment of cancer.
    Type: Application
    Filed: September 14, 2017
    Publication date: October 31, 2019
    Inventors: Sandrine CRABE, Didier SCHERRER, Hartmut EHRLICH, Philippe POULETTY
  • ANTIVIRAL POLYCLONAL ANTIBODIES AGAINST EBOLA VIRUS AND THE USES THEREOF
    Publication number: 20190185548
    Abstract: The present invention relates to polyclonal antibodies for use in the prevention and/or treatment of the Ebola virus disease. In one embodiment, the polyclonal antibodies are specific for a truncated Ebola virus GP glycoprotein. Said polyclonal antibodies are preferably non-human antibodies and are provided in a serum free pharmaceutical composition. The present invention also relates to a method of prevention and/or treatment of Ebola virus disease in a subject in need thereof, comprising administering to said subject polyclonal antibodies specific for the Ebola virus.
    Type: Application
    Filed: June 6, 2017
    Publication date: June 20, 2019
    Inventors: Sandrine CRABE, Jerome DENIS, Bernard FANGET